[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100272899":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":24,"responsibleParty":58,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Charite University, Berlin, Germany","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Study group",null,"POCD data of study patients of the following studies:\n\nPhydelio - Eudract.-No.: 2008-007237-47 - 08\u002F0618 ZS EK11 Neuprodex - Eudract-No.: 2013 -000823-15 - 13\u002F0491 ZSEK11 BioCog - EA2\u002F092\u002F14 Cognitive Outcome after two stage liver operation - EA1\u002F296\u002F12 ReCosa - EA1\u002F056\u002F13 Hypnoc - EA1\u002F273\u002F11 Sudoco - EA1\u002F242\u002F08 Peratecs - EA1\u002F241\u002F08 Hipster - Eudract.-No.: 2009-016043-19 100\u002F10 ZS EK15 Pain-Long-EA2\u002F041\u002F17 PCI - EA2\u002F024\u002F18 PODSPA - EA4\u002F138\u002F18, PRÄP-GO -EA1\u002F225\u002F19, ANA-PRÄP-Go (EA1\u002F266\u002F20) Further studies from the Department of Anesthesiology and Operative Intensive Care Medince (CCM\u002FCVK), Charité - Universitätsmedizin Berlin",{"label":13,"type":10,"description":14,"interventionNames":10},"Control group I","POCD data of prospective control subjects\u002Fpatients (ASA I+II+III) and POCD data of control subjects\u002Fpatients of the following studies:\n\nNeuprodex - Eudract-No.: 2013 -000823-15 - 13\u002F0491 ZSEK11 Phydeliostudie - Eudract.-No.: 2008-007237-47 - 08\u002F0618 ZS EK11 BioCog - EA2\u002F092\u002F14 Cognitive Outcome after two stage liver operation - EA1\u002F296\u002F12 Hypnoc - EA1\u002F273\u002F11 Sudoco - EA1\u002F242\u002F08 Peratecs - EA1\u002F241\u002F08 Hipster - Eudract.-No.: 2009-016043-19 100\u002F10 ZS EK15 BioCog-Studie - EA2\u002F092\u002F14 REACT-Studie - EA2\u002F091\u002F15 PAINLONG-Studie - EA2\u002F041\u002F17 PCI - EA2\u002F024\u002F18 PODSPA - EA4\u002F138\u002F18, PRÄP-GO -EA1\u002F225\u002F19, ANA-PRÄP-Go (EA1\u002F266\u002F20) Further studies from the Department of Anesthesiology and Operative Intensive Care Medince (CCM\u002FCVK), Charité - Universitätsmedizin Berlin",[16],{"name":17,"affiliation":5,"role":18},"Claudia Spies, MD, Prof.","STUDY_DIRECTOR",[20],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","+49 30 450 5510 01","claudia.spies@charite.de",[25,43],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Irmgard Landgraf","NOT_YET_RECRUITING","Berlin","12163","Germany","DE",{"type":33,"coordinates":34},"Point",[35,36],13.41053,52.52437,{"lat":36,"lon":35},[39],{"name":40,"role":21,"phone":41,"phoneExt":10,"email":42},"Irmgard Landgraf, MD","+49 30 450 85726877","praxislandgraf@gmail.com",{"facility":44,"status":45,"city":28,"state":10,"zip":46,"country":30,"countryCode":31,"cosmosGeoPoint":47,"geoPoint":49,"contacts":50},"Department of Anesthesiology and Operative Intensive Care Medicine Berlin (CCM, CVK), Charité - Universitätsmedizin Berlin","RECRUITING","13353",{"type":33,"coordinates":48},[35,36],{"lat":36,"lon":35},[51,53,55],{"name":17,"role":21,"phone":52,"phoneExt":10,"email":23},"+49 30 450 55 10 01",{"name":17,"role":54,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Friedrich Borchers, MD","SUB_INVESTIGATOR",{"type":54,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Claudia Spies","Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK)","100272899","retrospective-evaluation-of-pocd-data-of-studies-from-kai-charit---universittsmedizin-berlin-100272899",false,"NCT02832193","Retrospective Evaluation of POCD Data of Studies From KAI, Charité - Universitätsmedizin Berlin","Retrospective Evaluation of POCD Data of Studies From the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK) Charité - Universitätsmedizin Berlin","Study Group\n\nInclusion Criteria:\n\n* Age 18 -100 years\n* Male or female patients undergoing elective surgery expected to last at least 60 min, screened at the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany\n* Written informed consent to participate after having been properly instructed\n\nExclusion Criteria:\n\n* Lacking willingness to take part in the study, or to have relevant study data collected, saved and analyzed for the purpose of the study\n* Accommodation in an institution due to an official or judicial order\n* Insufficient knowledge of German language\n* Members of the hospital staff\n* Homelessness or other conditions that disable reachability for postoperative assessment by post or telephone\n* Illiteracy\n* Patients who had a history of neurologic deficits (e.g. stroke, history of seizures, etc.)\n* Hearing impairment that severely affects the neuropsychological testing.\n* Visual impairment that severely affects the neuropsychological testing.\n* Participation in other prospective clinical interventional trials\n\nControl Group\n\nInclusion Criteria:\n\n* Age 18 - 100 years\n* Male or female patients (ASA Status I, II+III)\n* No planned surgery during the next 3 months\n* No surgery during the past 6 months before study inclusion\n* Written informed consent to participate after having been properly instructed\n\nExclusion Criteria:\n\n* Insufficient knowledge of German language Lacking willingness to take part in the study, or to have relevant study data collected, saved and analyzed for the purpose of the study\n* Neuropsychiatric conditions that severely affect the neuropsychological testing\n* Hearing impairment that severely affects the neuropsychological testing\n* Visual impairment that severely affects the neuropsychological testing",true,"ALL","18 Years","100 Years",{"count":73,"type":74},5000,"ESTIMATED","OBSERVATIONAL","Data on prevention of perioperative neurocognitive disorders (pNCDs) are limited. The purpose of this monocentric parallel - grouped observational registry is to collect study data from studies with pNCDs as primary or secondary endpoint to estimate prevalence and incidence of pNCDs.",[78],"Postoperative Cognitive Dysfunction","2025-11-25",{"date":81,"type":82},"2025-11-26","ACTUAL",{"date":84,"type":82},"2009-03",{"date":86,"type":74},"2027-12",{"name":5,"class":6},2]